We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $1.8B
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+0.37%
1 Year Est. Return
+36.16%
3 Year Est. Return
+116.66%
5 Year Est. Return
+140.56%
10 Year Est. Return
+771.9%
AUM
$1.8B
AUM Growth
-$20.8M
Cap. Flow
+$57.1M
Cap. Flow %
3.18%
Top 10 Hldgs %
23.87%
Holding
255
New
12
Increased
107
Reduced
96
Closed
12

Top Buys

Rank Stock Value
1
GDDY icon
GoDaddy
GDDY
+$28M
2
UPWK icon
Upwork
UPWK
+$20.6M
3
G icon
Genpact
G
+$18.4M
4
FOUR icon
Shift4
FOUR
+$10.2M
5
SRAD icon
Sportradar
SRAD
+$8.21M

Sector Composition

Rank Sector Weight
1 Healthcare 31.73%
2 Technology 29.93%
3 Industrials 16.4%
4 Consumer Discretionary 7.95%
5 Communication Services 4.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LGND icon
1
Ligand Pharmaceuticals
LGND
$5.96B
$56.6M 3.15%
283,567
+3,940
+1% +$780K
FN icon
2
Fabrinet
FN
$16.9B
$55.2M 3.07%
105,815
-701
-0.7% -$356K
ARLO icon
3
Arlo Technologies
ARLO
$1.51B
$52.1M 2.9%
3,659,888
+83,276
+2% +$1.11M
XPO icon
4
XPO
XPO
$24.4B
$43.6M 2.43%
224,299
+5,123
+2% +$918K
ACIW icon
5
ACI Worldwide
ACIW
$5.88B
$41.1M 2.29%
1,003,356
+22,042
+2% +$926K
LRN icon
6
Stride
LRN
$3.83B
$38.7M 2.15%
438,440
+10,657
+2% +$864K
FOUR icon
7
Shift4
FOUR
$3.96B
$37.1M 2.06%
847,726
+183,938
+28% +$10.2M
DFIN icon
8
Donnelley Financial Solutions
DFIN
$1.26B
$36.8M 2.05%
780,037
+14,098
+2% +$691K
ASND icon
9
Ascendis Pharma A/S
ASND
$16.6B
$33.9M 1.89%
148,386
+3,340
+2% +$749K
ZD icon
10
Ziff Davis
ZD
$1.93B
$33.6M 1.87%
799,818
+55,586
+7% +$2.04M
ESTA icon
11
Establishment Labs
ESTA
$2.71B
$31.2M 1.73%
548,674
-102,885
-16% -$7.03M
PBH icon
12
Prestige Consumer Healthcare
PBH
$2.39B
$30.9M 1.72%
521,622
+21,022
+4% +$1.36M
KNSA icon
13
Kiniksa Pharmaceuticals
KNSA
$4.89B
$29.3M 1.63%
608,416
+11,985
+2% +$531K
AWI icon
14
Armstrong World Industries
AWI
$7.05B
$29.1M 1.62%
176,857
+3,883
+2% +$710K
YOU icon
15
Clear Secure
YOU
$5.36B
$27.9M 1.56%
577,081
-337,154
-37% -$13.4M
WEX icon
16
WEX
WEX
$6.07B
$27.6M 1.54%
180,314
+6,176
+4% +$965K
WIX icon
17
WIX.com
WIX
$2.36B
$26.7M 1.49%
296,787
+46,703
+19% +$3.9M
SRAD icon
18
Sportradar
SRAD
$4.34B
$26.5M 1.47%
1,582,182
+441,765
+39% +$8.21M
GDDY icon
19
GoDaddy
GDDY
$12.8B
$26.4M 1.47%
319,453
+295,218
+1,218% +$28M
G icon
20
Genpact
G
$5.45B
$26.2M 1.46%
704,124
+445,743
+173% +$18.4M
ITRN icon
21
Ituran Location and Control
ITRN
$1.09B
$26.1M 1.45%
531,854
+3,690
+0.7% +$174K
MEDP icon
22
Medpace
MEDP
$16.5B
$25.9M 1.44%
53,983
-8,531
-14% -$4.37M
SUPN icon
23
Supernus Pharmaceuticals
SUPN
$2.73B
$24.7M 1.37%
477,416
+9,530
+2% +$485K
NGVT icon
24
Ingevity
NGVT
$2.59B
$24.6M 1.37%
345,138
+7,643
+2% +$523K
BCRX icon
25
BioCryst Pharmaceuticals
BCRX
$2.43B
$21.2M 1.18%
2,230,105
+325,959
+17% +$2.53M

Similar funds

Rice Hall James & Associates's Q1 2026 Portfolio in Review

As of Q1 2026, Rice Hall James & Associates held 255 positions worth $1.8B, down 1.1% from $1.82B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Rice Hall James & Associates deployed $57.1M of net new capital in Q1 2026, opening 12 new positions and adding to 107 existing holdings. Its largest new stake was Upwork: 1,308,167 shares worth $14.3M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 35% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Amicus Therapeutics, an estimated $39.3M trimmed.

  • Rice Hall James & Associates's largest Q1 2026 buy was Upwork: 1,308,167 shares worth $14.3M.
  • Rice Hall James & Associates added most to GoDaddy in Q1 2026, an estimated $28M increase.
  • Rice Hall James & Associates's biggest Q1 2026 reduction was Amicus Therapeutics, cutting an estimated $39.3M.
  • Rice Hall James & Associates fully exited iShares Micro-Cap ETF in Q1 2026, selling an estimated $4.53M.
  • Rice Hall James & Associates's ten largest holdings make up 24% of its $1.8B portfolio in Q1 2026.
  • Rice Hall James & Associates opened 12 new positions and closed 12 in Q1 2026.
  • Rice Hall James & Associates's portfolio value fell 1.1% quarter-over-quarter to $1.8B.

Based on Rice Hall James & Associates's 13F filing for Q1 2026, filed 15 May 2026.